CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($) $ in Thousands	Shares of Common Stock	Common Stock and Additional Paid in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Total
Balance, beginning of period at Dec. 31, 2016		$ 61,583	$ 17,206	$ (180)	$ 78,609
Balance (in shares) at Dec. 31, 2016	6,263,371
Increase (Decrease) in Shareholders' Equity
Net income for period			5,499		5,499
Other comprehensive income
Net unrealized (loss) gain on securities available for sale				509	509
Total comprehensive income			5,499	509	6,008
Stock compensation		298			298
Restricted stock award vesting (in shares)	31,559
Dividend on common stock			(2,266)		(2,266)
Balance, end of period at Sep. 30, 2017		61,881	20,439	329	82,649
Balance (in shares) at Sep. 30, 2017	6,294,930
Balance, beginning of period at Dec. 31, 2017		61,981	19,711	(292)	81,400
Balance (in shares) at Dec. 31, 2017	6,294,930
Increase (Decrease) in Shareholders' Equity
Net income for period			5,002		5,002
Other comprehensive income
Net unrealized (loss) gain on securities available for sale				(735)	(735)
Total comprehensive income			5,002	(735)	4,267
Stock compensation		475			475
Restricted stock award vesting (in shares)	45,630
FFNM acquisition		34,101			34,101
FFNM acquisition (in shares)	2,146,378
Capital raise, net of offering costs		32,451			32,451
Capital raise, net of offering costs (in shares)	2,225,807
Dividend on common stock			(3,327)		(3,327)
Balance, end of period at Sep. 30, 2018		$ 129,008	$ 21,386	$ (1,027)	$ 149,367
Balance (in shares) at Sep. 30, 2018	10,712,745